Lars Nieba

Gmail Google Apps Microsoft Office 365 Google Cloud Hosting Mobile Friendly Wix Varnish Render Basis AI

immunotherapy t cell therapy oncology machine learning biotechnology immunology precision immunotherapy soluble t-cell receptors tcr drugs cancer treatment solid tumours targeted therapy immune-mediated diseases ai-guided protein engineering multi-specific tcrs high target affinity enhanced stability immune responses biotherapeutics development clinical candidate selection tcr-t cell therapies tumour antigens high-affinity binding intracellular antigens sustained immune responses biodistribution effector immune cells specificity-guided maturation trispecific tcrs networking & alliances therapeutic candidates autoantigen recognition novel therapeutic platforms soluble tcr therapies preclinical development pipeline programs molecular design oncology indication inflammatory diseases bioengineering cancer immunotherapy safety profiles drug development biological drugs targeted treatments clinical studies healthcare innovation therapeutic potential disease management patient-centric therapies high-throughput screening tissue-targeted therapy receptor engagement immune system modulation receptor co-stimulation hospital & health care artificial intelligence information technology & services